{"name":"Instituto do Cancer do Estado de São Paulo","slug":"instituto-do-cancer-do-estado-de-s-o-paulo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Local steroid - triamcinolone acetonide","genericName":"Local steroid - triamcinolone acetonide","slug":"local-steroid-triamcinolone-acetonide","indication":"Local inflammatory skin conditions (eczema, psoriasis, lichen planus)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Mitomycins","genericName":"Mitomycins","slug":"mitomycins","indication":"Other","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Oral steroid - predonisolone","genericName":"Oral steroid - predonisolone","slug":"oral-steroid-predonisolone","indication":"Adjunctive treatment in cancer therapy to manage inflammation and side effects","status":"marketed"}]}],"pipeline":[{"name":"Local steroid - triamcinolone acetonide","genericName":"Local steroid - triamcinolone acetonide","slug":"local-steroid-triamcinolone-acetonide","phase":"marketed","mechanism":"Triamcinolone acetonide is a synthetic corticosteroid that suppresses local inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Local inflammatory skin conditions (eczema, psoriasis, lichen planus)","Intralesional treatment of keloids and hypertrophic scars","Intra-articular injection for inflammatory arthritis","Oral aphthous ulcers and oral lichen planus"],"catalyst":""},{"name":"Mitomycins","genericName":"Mitomycins","slug":"mitomycins","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oral steroid - predonisolone","genericName":"Oral steroid - predonisolone","slug":"oral-steroid-predonisolone","phase":"marketed","mechanism":"Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Adjunctive treatment in cancer therapy to manage inflammation and side effects","Lymphoproliferative disorders","Autoimmune complications in cancer patients"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}